Rac1-Abi-1 Signaling Links DNA Repair to Tumorigenesis

The DNA damage response governs genomic integrity, and abnormal DNA repair can drive tumorigenesis. We previously identified a Rac1-Abi-1 signaling pathway in which Rac1 activates protein phosphatase 5, leading to Abi-1-S323 dephosphorylation and enhanced non-homologous end joining (NHEJ). Given the error-prone nature of NHEJ and its potential to promote genomic instability, we sought to determine whether Rac1-Abi-1-mediated regulation of NHEJ contributes to tumorigenesis. Here, we demonstrate the tumorigenic role of Abi-1-S323 dephosphorylation in nonmalignant cell models and multiple tumorigenesis models established using a newly generated genetically engineered Abi-1 mouse model. We first found that the dephospho-mimetic Abi-1-S323A mutant promoted transformation-associated phenotypes in nonmalignant human cells and enhanced orthotopic glioblastoma growth under unperturbed conditions. To further investigate its tumorigenic potential in vivo, we generated CRISPR/Cas9-mediated Abi-1-S296A knock-in mice, in which S296 corresponds to human S323. Abi-1-S296A mouse embryonic fibroblasts exhibited increased proliferation, while mutant mice developed spontaneous tumors involving lymphoid tissues and organs under unperturbed conditions. Furthermore, Abi-1-S296A increased susceptibility to tumorigenesis following DNA damage. In a low-dose whole-body irradiation model, Abi-1-S296A mice showed a trend toward shortened survival and increased tumor development, with lesions including Harderian gland papillary cystadenomas, round-cell neoplasms, and anaplastic sarcomas. In addition, in an azoxymethane/dextran sulfate sodium (AOM/DSS)-induced colorectal tumor model, Abi-1-S296A mice developed significantly more tumors and had a greater tumor burden. These findings identify Abi-1-S323 dephosphorylation as a previously unrecognized regulator of tumorigenesis and establish a new mouse model for investigating the physiological and pathological consequences of constitutive activation of upstream NHEJ-regulatory signaling.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.13.766481
Primary Topic
DNA Repair Mechanisms
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Rac1-Abi-1 Signaling Links DNA Repair to Tumorigenesis

Thomas L. Saunders, Sriram Venneti, Meredith Ann Morgan, Yatrik Madhukar Shah et al.
bioRxiv (Cold Spring Harbor Laboratory)
DNA Repair Mechanisms
preprint

Rac1-Abi-1 Signaling Links DNA Repair to Tumorigenesis

Thomas L. Saunders, Sriram Venneti, Meredith Ann Morgan, Yatrik Madhukar Shah, Angelica Lin, Daniel Richard Wahl, Zachary T. Freeman, Sumeet A. Solanki, Menggang Yu, Weihua Zhou, Yuezhong Zhang, Kari Wilder-Romans, Wilson Zheng, Honglai Zhang, Elizabeth C. McCulla, Mingjia Tan, Jihan Park, Timothy Jho, Theodore S. Lawrence, Ziqing Zhu, Yiheng Huang, Jie Xu, Jing Li, Daven Kothari, Benjamin Curtis
preprint en

Abstract

The DNA damage response governs genomic integrity, and abnormal DNA repair can drive tumorigenesis. We previously identified a Rac1-Abi-1 signaling pathway in which Rac1 activates protein phosphatase 5, leading to Abi-1-S323 dephosphorylation and enhanced non-homologous end joining (NHEJ). Given the error-prone nature of NHEJ and its potential to promote genomic instability, we sought to determine whether Rac1-Abi-1-mediated regulation of NHEJ contributes to tumorigenesis. Here, we demonstrate the tumorigenic role of Abi-1-S323 dephosphorylation in nonmalignant cell models and multiple tumorigenesis models established using a newly generated genetically engineered Abi-1 mouse model. We first found that the dephospho-mimetic Abi-1-S323A mutant promoted transformation-associated phenotypes in nonmalignant human cells and enhanced orthotopic glioblastoma growth under unperturbed conditions. To further investigate its tumorigenic potential in vivo, we generated CRISPR/Cas9-mediated Abi-1-S296A knock-in mice, in which S296 corresponds to human S323. Abi-1-S296A mouse embryonic fibroblasts exhibited increased proliferation, while mutant mice developed spontaneous tumors involving lymphoid tissues and organs under unperturbed conditions. Furthermore, Abi-1-S296A increased susceptibility to tumorigenesis following DNA damage. In a low-dose whole-body irradiation model, Abi-1-S296A mice showed a trend toward shortened survival and increased tumor development, with lesions including Harderian gland papillary cystadenomas, round-cell neoplasms, and anaplastic sarcomas. In addition, in an azoxymethane/dextran sulfate sodium (AOM/DSS)-induced colorectal tumor model, Abi-1-S296A mice developed significantly more tumors and had a greater tumor burden. These findings identify Abi-1-S323 dephosphorylation as a previously unrecognized regulator of tumorigenesis and establish a new mouse model for investigating the physiological and pathological consequences of constitutive activation of upstream NHEJ-regulatory signaling.

bioRxiv (Cold Spring Harbor Laboratory)
University of Michigan (US), Cell Signaling Technology (United States) (US)
National Science Foundation, National Cancer Institute
Good health and well-being
DNA Repair Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon